Zobrazeno 1 - 10
of 154
pro vyhledávání: '"inhibice"'
Autor:
Králová, Kristýna
CHARLES UNIVERSITY FACULTY OF PHARMACY IN HRADEC KRÁLOVÉ DEPARTMENT OF PHARMACOGNOSY AND PHARMACEUTICAL BOTANY CANDIDATE: Kristýna Králová SUPERVISOR: prof. Ing. Lucie Cahlíková, Ph.D. CONSULTANT: Mgr. Filip Pidaný TITLE OF DIPLOMA THESIS: Am
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2186::e8786de3db0cf64ae060495d556f4eff
http://www.nusl.cz/ntk/nusl-528005
http://www.nusl.cz/ntk/nusl-528005
Autor:
Srogoň, Jiří
Lenvatinib is a multi-targeted kinase inhibitor capable of inhibiting these kinases at nanomolar concentrations. For this reason, it is used as a drug in the treatment of various types of cancer. Like many other xenobiotics, lenvatinib is metabolized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2186::254b1814c4489b73a4de0bcce8d66773
http://www.nusl.cz/ntk/nusl-528513
http://www.nusl.cz/ntk/nusl-528513
Autor:
Drejslarová, Iva
Cytochromes P450 are enzymes involved in many physiological processes in the body, besides the metabolism of xenobiotics also in the biosynthesis and catabolism of endogenous substances such as hormones and steroids. Cytochromes P450 that are respons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2186::7badc53f2c78c82419e7bc71ad631e78
http://www.nusl.cz/ntk/nusl-527807
http://www.nusl.cz/ntk/nusl-527807
Autor:
Čápová, Kateřina
PfMSP3.1 is one of the surface proteins of the intracellular parasite Plasmodium falciparum, which causes malaria. As one of the evasion strategies of the immunity system of the human host this protein interacts with one regulator of the complement s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2186::dc267abbf26d9d496d9b64cb147cf215
http://www.nusl.cz/ntk/nusl-528961
http://www.nusl.cz/ntk/nusl-528961
Autor:
Šimková, Adéla
The topic of this thesis is the synthesis of rhodanine derivatives and evaluation of their biological activity, particularly as potential cholinesterases inhibitors. This group of compounds is important for treatment of many diseases, e.g., Alzheimer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2186::fae257c81da8c5d0c0096baafcf3e10a
http://www.nusl.cz/ntk/nusl-528133
http://www.nusl.cz/ntk/nusl-528133